← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2009Last known activity
Apr 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (10 distinct, 8 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Recent trials (12)
- NCT06745063OfficialPhase 2Apr 1, 2025
- NCT05526144Overall official - principal investigatorPhase 2Jan 1, 2023
- NCT05205005Overall official - principal investigatorPhase 2/Phase 3May 25, 2022
- NCT05744115CollaboratorPhase 3Jul 27, 2021
- NCT05744115Lead sponsorPhase 3Jul 27, 2021
- NCT05744115Sponsor investigatorPhase 3Jul 27, 2021
- NCT04680221CollaboratorPhase 4Mar 1, 2021
- NCT02630719CollaboratorN/AJan 1, 2016
- NCT00657228Overall official - principal investigatorN/ADec 1, 2009
- NCT00657228CollaboratorN/ADec 1, 2009
- NCT00547716Overall official - principal investigatorN/AJun 1, 2009
- NCT00547716CollaboratorN/AJun 1, 2009
Details
- Last known activity
- Apr 1, 2025